文献速递流行病学与生物统计临床试验与 GCP

用于随机II期临床试验的改进贝叶斯择优(IBPW)设计

An Improved Bayesian Pick-the-Winner (IBPW) Design for Randomized Phase II Clinical Trials.
PubMed 文献 · Stat Med · 2026-01-01

针对随机II期多臂试验中贝叶斯择优(BPW)设计难以控制总I类和II类错误的问题,提出改进的随机两阶段贝叶斯择优(IBPW)设计,将择优决策形式化为假设检验,在灵活假设下严格控制错误并优化样本量与决策界值。模拟研究显示新设计在保留BPW优点的同时改善了择优操作特性。

要点

  • IBPW设计将择优决策形式化为假设检验,严格控制总I类和II类错误。
  • 该设计通过优化样本量和决策界值,在灵活假设下实现高效决策。
  • 模拟研究表明IBPW在保留BPW设计优点的同时改善了择优操作特性。

核心结论

  • 提出的IBPW设计在保留BPW设计优点的同时,为择优选择提供了改善的操作特性。

研究设计与样本

  • 方法学文章,提出改进的随机两阶段贝叶斯择优(IBPW)设计,并通过模拟研究评估其操作特性。

主要发现

  • 模拟研究表明,与BPW设计相比,IBPW设计在择优选择方面提供了改善的操作特性,同时保留了BPW设计的优点。

关键数值与推荐

  • IBPW设计将择优选择形式化为假设检验,在两治疗臂择优的灵活假设集下严格控制I类和II类错误,并优化样本量和决策界值。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Phase II clinical trials play a pivotal role in drug development by screening a large number of drug candidates to identify those with promising preliminary efficacy for phase III testing. Trial designs that enable efficient decision-making with small sample sizes and early futility stopping while controlling for type I and type II errors in hypothesis testing, such as Simon's two-stage design, are preferred. Randomized multi-arm trials are increasingly used in phase II settings to overcome the limitations associated with using historical controls as the reference. However, how to effectively balance efficiency and accurate decision-making continues to be an important research topic. A notable development in phase II randomized design methodology is the Bayesian pick-the-winner (BPW) design proposed by Chen et al. [1]. Despite multiple appealing features, this method cannot easily control for overall type I and type II errors for winner selection. Here, we introduce an improved randomized two-stage Bayesian pick-the-winner (IBPW) design that formalizes the winner-selection based hypothesis testing, optimizes sample sizes and decision cut-offs by strictly controlling the type I and type II errors under a set of flexible hypotheses for winner-selection across two treatment arms. Simulation studies demonstrate that our new design offers improved operating characteristics for winner selection while retaining the desirable features of the BPW design.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Lei W, Peng M, Altorki N, et al. An Improved Bayesian Pick-the-Winner (IBPW) Design for Randomized Phase II Clinical Trials. Stat Med. 2026. PMID: 41569686. doi:10.1002/sim.70348

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。